Paediatric snakebite envenoming: the world's most neglected 'Neglected Tropical Disease'?

Sophie Pach1, Jacqueline Le Geyt2, José María Gutiérrez3

  • 1General Medicine, Royal Free London NHS Foundation Trust, London, UK.

Insights

Snakebites severely impact impoverished children. This study addresses snakebite epidemiology, socioeconomic effects, and prevention strategies, highlighting antivenom challenges.

Area of Science:

  • Global Health
  • Tropical Medicine
  • Epidemiology

Background:

  • Snakebite envenoming disproportionately affects children in impoverished rural areas.
  • The World Health Organization (WHO) recognizes snakebites as a Neglected Tropical Disease.
  • A comprehensive WHO strategy for prevention and control is now in place.

Purpose of the Study:

  • To describe the epidemiology and socioeconomic impact of snakebite.
  • To outline key prevention strategies for snakebite envenoming.
  • To explore challenges and priorities in antivenom production and distribution.

Main Methods:

  • Epidemiological data analysis.
  • Socioeconomic impact assessment.
  • Review of current prevention strategies and antivenom supply chains.

Main Results:

  • Snakebite's significant burden on vulnerable populations.
  • Identification of critical gaps in prevention and control measures.
  • Challenges in ensuring access to safe and effective antivenom.

Conclusions:

  • Snakebite requires urgent, targeted interventions, especially for children in low-resource settings.
  • Effective prevention and control necessitate addressing socioeconomic determinants and improving antivenom accessibility.
  • Continued research and policy focus on antivenom production and equitable distribution are crucial.

Related Concept Videos

Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.4K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
165
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
108
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
144
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.1K